Hawaii bills · 2026 Regular Session
Hawaii SB 2221
RELATING TO TERMINAL ILLNESSES.
- Introduced
- In committee
- Passed Senate
- Passed House
- To Governor
- Became law
Sponsors
Cosponsors (1)
- San Buenaventura (Democratic)
Summary
Official abstract published by the Hawaii legislature· description
Authorizes manufacturers of investigational drugs or biological products that are pending approval by the United States Food and Drug Administration to make the drugs or products available to terminally ill patients under certain conditions.
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Jan 14, 2026 · Senate
Pending Introduction. - Jan 21, 2026 · Senate
Introduced and passed First Reading. - Jan 26, 2026 · Senate
Referred to HHS, CPN/JDC.